Depigmentation Agents

Cosmeceuticals and Active Cosmetics: Drugs Versus Cosmetics, Second Edition

Volumn , Issue , 2005, Pages 185-206

  Nakayama, Hideo ^a   Ebihara, Tamotsu ^b   Satoh, Noriko ^c   Jinnai, Tsuneo ^d  

^a Nakayama Dermatology Clinic   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c Yanagihara Hospital   (Japan)

^d Sansho Seiyaku Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41349099801     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/NOE0824759438-14     Document Type: Chapter

References (19)

1. Sato N. Endocrine environment in adult females with chloasma. Jpn J Dermatol 1987; 97(8):937–943.
2. Sanchez NP, Pathak MA, Sato S et al. Melasma. A clinical, light microscopic, ultra­structural, and immunofluorescence study. J Am Acad Dermatol 1981; 4:698–710.
3. Findlay GH. Ochronosis following skin bleaching with hydroquinone. J Am Acad Dermatol 1982; 6:1092–1093.
4. Nakayama H. Pigmented contact dermatitis and chemical depigmentation. In Text­book of Contact Dermatitis, 2d ed. Berlin: Springer-Verlag, 1995; 637–656.
5. Hoshaw RA, Zimmerman KG, Menter A. Ochronosis-like pigmentation from hydro­quinone bleaching creams in American Blacks. Arch Dermatol 1985; 121:105–108.
6. Gracia A, Fulton Jr. JE. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22:443–447.
7. Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol 1998; 25:587–596.
8. Mishima Y, Hata S, Ohyama Y, Inazu M. Induction of melanogenesis suppression: cellular pharmacology and mode of differential action. Pigm Cell Res 1988; 1:367–374.
9. Kameyama K, Sakai C, Kondoh S et al. Inhibitory effect of magnesium L-ascorbyl-2- phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol 1996; 34:29–33.
10. Akiu S, Suzuki Y, Fujinuma Y et al. Inhibitory effect arbutin on melanogenesis. Bio­chemical study in cultured B16 melanoma cells and effect on the UV-induced pigmen­tation in human skin. Proc Jpn Invest Dermatol 1988; 12:138–139.
11. Maeda K, Fukuda M. In vitro effectiveness of several whitening cosmetic components in human melanocytes. J Soc Cosmet Chem 1991; 42:361–368.
12. Jimbow M, Marusyk H, Jimbow K. The in vivo melanocytotoxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair. Br J Derma­tol 1995; 133:526–536.
13. Nakayama H, Watanabe H, Nishioka K, Hayakawa R, Higa Y. Treatment of chlosama with kojic acid cream. Rinsho Hifuka 1982; 36:715–722.
14. Nakayama H, Sakurai M, Kumei A, Hanada S, Iwamoto A. The effect of kojic acid application on various facial pigmentary disorders. Nishinihon Hifuka 1994; 56:1172–1181.
15. Nakayama H, Matsuo S, Hayakawa K, Takahashi K et al. Pigmented cosmetic derma­titis. Int J Dermat 1984; 23:299–305.
16. Ebihara T, Nakayama H. Unusual and uncommon contact reactions: pigmented contact dermatitis. Clin Dermatol 1997; 15:593–599.
17. Nakagawa M, Kawai K, Kawai K. Contact allergy to kojic acid in skin care products. Contact Dermatitis 1995; 32:9–13.
18. Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis 1996; 57(suppl 1):36–45.
19. Jimbow K. N-acetyl-4-w-cyteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 1991; 127:1528–1534.